KurApp
HealthTech SaaSEvaluation date: 24 de Septiembre, 2026
What it sells
Modular SaaS software for outpatient care management and automated preventive triage.
Who it's for
Medium-sized clinics, outpatient medical centers, and private health coordinators (B2B).
How it makes money
Monthly recurring subscription (B2B SaaS) per medical site plus a tiered plan based on active patient volume.
Why now
Growing digitalization of the health sector in LatAm, primary care saturation, and the need to reduce operating costs and post-pandemic absenteeism.
Initial focus
Validation and capture of 20% of clinical coordinators in high-turnover urban outpatient centers.
The project KurApp has solid architecture and conceptualization foundations, but shows an excessively broad market scope. The methodological validation of the hypothesis requires closing the gap between the stated benefit and observable operational adoption.
Main Risk
The breadth of the target market makes it hard to prioritize acquisition channels and value messages.
Relative Strength
The team shows strong technical skill and a solid product architecture.
Analytical dimensions audited under a read-only protocol.
Problem
Focus on the pain point and recurrence of the friction users experience.
Team
Technical capabilities and operational execution of field validation.
Customer
Definition and focus of KurApp's Ideal Customer Profile (ICP).
Environment
Health regulations and direct substitutes in clinical operations.
Value
KurApp's measurable differential proposition versus manual solutions.
5 Critical Market Test Suggestions
Rigorous experimentation protocols with real users, free of theoretical assumptions or vanity metrics.
Validation of Pain Frequency and Intensity
Dimension: ProblemAudit, through structured interviews with 30 active health professionals whether the friction in KurApp occurs weekly and has driven an active search for a solution in the last 30 days, ruling out abstract opinions.
Competitive Substitution and Switching Cost Matrix
Dimension: EnvironmentTrack which manual solutions (shared spreadsheets or informal messaging) prospects currently use, and map out the habit-breaking cost needed for KurApp to be adopted without cultural resistance.
Early Commitment Experiment (Letter of Intent / LOI)
Dimension: ValueRequire preliminary closed-pilot agreements or formal Letters of Intent from at least 5 institutions or pilot clinics, contrasting verbal interest against a formal deployment commitment.
Strict Early Adopter Segmentation
Dimension: CustomerFocus the ICP on the 20% of clinical coordinators who face daily bottlenecks, excluding from the initial scope peripheral profiles whose demands dilute KurApp's core value proposition.
Comprehension Test with Non-Functional Prototype (<60s)
Dimension: Product / TeamExpose representative users to KurApp's main flow without guided assistance, evaluating whether they identify and articulate the core value proposition in under one minute of interaction.